Literature DB >> 26414754

Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy.

T Illidge1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26414754     DOI: 10.1016/j.clon.2015.09.001

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  4 in total

Review 1.  Background and Current Treatment of Squamous Cell Carcinoma of the Anus.

Authors:  Rob Glynne-Jones; Waqar Saleem; Mark Harrison; Suzy Mawdsley; Marcia Hall
Journal:  Oncol Ther       Date:  2016-08-01

2.  Where is clinical research for radiotherapy going? Cross-sectional comparison of past and contemporary phase III clinical trials.

Authors:  Sunmin Park; Chai Hong Rim; Won Sup Yoon
Journal:  Radiat Oncol       Date:  2020-02-14       Impact factor: 3.481

3.  Clinical development of new drug-radiotherapy combinations.

Authors:  Ricky A Sharma; Ruth Plummer; Julie K Stock; Tessa A Greenhalgh; Ozlem Ataman; Stephen Kelly; Robert Clay; Richard A Adams; Richard D Baird; Lucinda Billingham; Sarah R Brown; Sean Buckland; Helen Bulbeck; Anthony J Chalmers; Glen Clack; Aaron N Cranston; Lars Damstrup; Roberta Ferraldeschi; Martin D Forster; Julian Golec; Russell M Hagan; Emma Hall; Axel-R Hanauske; Kevin J Harrington; Tom Haswell; Maria A Hawkins; Tim Illidge; Hazel Jones; Andrew S Kennedy; Fiona McDonald; Thorsten Melcher; James P B O'Connor; John R Pollard; Mark P Saunders; David Sebag-Montefiore; Melanie Smitt; John Staffurth; Ian J Stratford; Stephen R Wedge
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

4.  Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer.

Authors:  Duncan C Gilbert; Eva Serup-Hansen; Dorte Linnemann; Estrid Høgdall; Charles Bailey; Jeff Summers; Hanne Havsteen; Gareth J Thomas
Journal:  Br J Cancer       Date:  2016-01-05       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.